| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 08/05/2026 | ±2.2% | +3.6% | under-priced |
| 05/06/2026 | ±2.2% | -17.4% | under-priced |
| 02/04/2026 | ±2.4% | -8.8% | under-priced |
| 08/06/2025 | ±2.0% | -2.9% | under-priced |
| 05/07/2025 | ±1.4% | +4.7% | under-priced |
| 02/05/2025 | ±1.6% | +0.7% | over-priced |
| 07/31/2024 | ±1.7% | +3.0% | under-priced |
| 05/01/2024 | ±1.2% | -4.1% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $3.94 | $84.8B | $777M |
| Q2 FY2026 | $8.40 | $78.4B | $1.6B |
| Q1 FY2026 | $2.87 | $85.9B | $566M |
| Q4 FY2025 | $-1.74 | $83.7B | $-333M |
Cencora, Inc. (COR) reports in 75 days, with the next report estimated for 11/26/2026. Across the last 8 reports, options priced an average ±1.8% earnings move while the stock actually moved 5.7% on average — the market has tended to under-price COR's earnings risk. Fundamentals into the print: EPS up 11.9% year-over-year, revenue up 5.1%. QuantLogix's live 5-factor engine currently reads COR as a buy at 58/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →